Delivery Order SPE2DB20D2104-SPE2DB23FQ68G

Award Date 10/11/22
Potential Completion Date 11/1/22
Potential Value $15K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,779.12 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,793.03 firm fixed-price delivery order is for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR, a specialty medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, running through November 2026. The IDC provides a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,586.06 Firm Fixed Price Delivery Order is for BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 8, 2024 and was awarded on October 18, 2024. This award is a delivery order under AmerisourceBergen's larger $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $11,168.02 firm fixed-price contract has an ultimate completion date of November 19, 2024 and was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,330.68, is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR, a specialty medication. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division. The IDC serves as a...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication, to the Defense Logistics Agency (DLA). The $5,402.70 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of October 16, 2023 and was awarded on September 22, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,379.09 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 16, 2024 with a completion date of November 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,586.06 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with no set-aside designation. The award is a task order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which serves as the primary vehicle for AmerisourceBergen to...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR medication to the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The $16,758.18 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, on October 8, 2024. The contract has an ultimate completion date of October 30, 2024 and is not set aside for any special business category. Amerisourcebergen has a significant Indefinite Delivery...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,379.43 Firm Fixed Price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FQ68G
    Delivery Order

This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $15,399.18 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen is the prime contractor, and the parent company is Cencora, Inc., which also does business as AmerisourceBergen. This contract supports the DLA's mission of providing essential medical commodities, including specialty medications, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 2/27/25, 11:39 AM